Establishing secure connection…Loading editor…Preparing document…

Lynton Group Inc Initial Statement Preliminary Form

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

LYNTON GROUP, INC. 1993 STOCK OPTION PLAN

1. Purpose: Effectiveness of the Plan.

a. The purpose of this Plan is to advance the interests of the Company and its stockholders by helping the Company obtain and retain the services of employees, officers, consultants, and directors, upon whose judgment, initiative and efforts the Company is substantially dependent, and to provide those persons with further incentives to advance the interests of the Company.

b. This Plan will become effective on the date of its adoption by the Board, provided the Plan is approved by the stockholders of the Company (excluding holders of shares of Stock issued by the Company pursuant to the exercise of options granted under this Plan) within twelve months before or after that date. If the Plan is not so approved by the stockholders of the Company, any options granted under this Plan will be rescinded and will be void. This Plan will remain in effect until it is terminated by the Board or the Committee (as defined hereafter) under section 9 hereof, except that no ISO (as defined herein) will be granted after the tenth anniversary of the date of this Plan's adoption by the Board. This Plan will be governed by, and construed in accordance with, the laws of the State of Delaware.

2. Certain Definition.

Unless the context otherwise requires, the following defined terms (together with other capitalized terms defined elsewhere in this Plan) will govern the construction of this Plan, and of any stock option agreements entered into pursuant to this Plan:

a. "10% Stockholder" means a person who owns, either directly or indirectly by virtue of the ownership attribution provisions set forth in Section 424(d) of the Code at the time he or she is granted an Option, stock possessing more than ten percent (10%) of the total combined voting power or value of all classes of stock of the Company and/or of its subsidiaries;

b. "1933 Act" means the federal Securities Act of 1933, as amended;

c. "Board" means the Board of Directors of the Company;

d. "Called for under an Option," or words to similar effect, means issuable pursuant to the exercise of an Option;

e. "Code" means the Internal Revenue Code of 1986, as amended;

f. "Committee" means a committee of two or more Disinterested Directors, appointed by the Board, to administer and interpret this Plan; provided that the term "Committee" will refer to the Board during such times as no Committee is appointed by the Board;

g. "Company" means Lynton Group, Inc., a Delaware corporation;

h. "Disability" has the same meaning as "permanent and total disability," as defined in Section 22(c)(3) of the Code;

i. "Disinterested Director" means a member of the Board who is not during the period of one year prior to his or her service as an administrator of the Plan, or during the period of such service, granted or awarded Stock, options to acquire Stock, or similar equity securities of the Company under this Plan or any similar plan of the Company, other than the grant of a Formula Option pursuant to section 6(m) of this Plan;

j. "Eligible Participants" means persons who, at a particular time, are employees, officers, consultants, or directors of the Company or its subsidiaries;

k. "Fair Market Value" means, with respect to the Stock and as of the date an ISO or a Formula Option is granted hereunder, the market price per share of such Stock determined by the Committee, consistent with the requirements of Section 422 of the Code;

i. If the Stock was traded on a stock exchange on the date in question, then the Fair Market Value will be equal to the closing price reported by the applicable composite-transactions report for such date;

ii. If the Stock was traded over-the-counter on the date in question and was classified as a national market issue, then the Fair Market Value will be equal to the last-transaction price quoted by the NASDAQ system for such date;

iii. If the Stock was traded over-the-counter on the date in question but was not classified as a national market issue, then the Fair Market Value will be equal to the average of the last reported representative bid and asked prices quoted by the NASDAQ system for such date; and

iv. If none of the foregoing provisions is applicable, then the Fair Market Value will be determined by the Committee in good faith on such basis as it deems appropriate.

l. "Formula Option" means an NSO granted to members of the Committee pursuant to section 6(m) hereof;

m. "ISO" has the same meaning as "incentive stock option," as defined in Section 422 of the Code;

n. "Just Cause Termination" means a termination by the Company of an Optionee's employment by and/or service to the Company in connection with the good faith determination of the Company's board of directors that the Optionee has engaged in any acts involving dishonesty or moral turpitude or in any acts that materially and adversely affect the business, affairs or reputation of the Company or its subsidiaries;

o. "NSO" means any option granted under this Plan whether designated by the Committee as a "nonqualified stock option," a "non-statutory stock option" or otherwise, other than an option designated by the Committee as an ISO, or any option so designated but which, for any reason, fails to qualify as an ISO pursuant to Section 422 of the Code and the rules and regulations thereunder;

p. "Option" means all option granted pursuant to this Plan entitling the option holder to acquire shares of Stock issued by the Company pursuant to the valid exercise of the option;

q. "Option Agreement" means an agreement between the Company and an Optionee, in form and substance satisfactory to the Committee in its sole discretion, consistent with this Plan;

r. "Option Price" with respect to any particular Option means the exercise price at which the Optionee may acquire each share of the Option Stock called for under such Option;

s. "Option Stock" means Stock issued or issuable by the Company pursuant to the valid exercise of an Option;

t. "Optionee" means an Eligible Participant to whom Options are granted hereunder, and any transferee thereof pursuant to a Transfer authorized under this Plan;

u. "Plan" means this 1993 Stock Option Plan of the Company;

v. "QDRO" has the same meaning as "qualified domestic relations order" as defined in Section 414(p) of the Code;

w. "Stock" means shares of the Company's Common Stock, $.05 par value;

x. "Subsidiary" has the same meaning as "Subsidiary Corporation" as defined in Section 424(f) of the Code;

y. "Transfer," with respect to Option Stock, includes, without limitation, a voluntary or involuntary sale, assignment, transfer, conveyance, pledge, hypothecation, encumbrance, disposal, loan, gift, attachment or levy of such Option Stock.

3. Eligibility.

The Company may grant Options under this Plan only to persons who are Eligible Participants as of the time of such grant. Subject to the provisions of sections 4(d), 5 and 6 hereof, the Committee shall have complete discretion to determine the number of Options that may be granted to an Eligible Participant.

4. Administration.

a. Committee. The Committee, if appointed by the Board, will administer this Plan. If the Board, in its discretion, does not appoint such a Committee, the Board itself will administer this Plan and take such other actions as the Committee is authorized to take hereunder.

b. Authority and Discretion of Committee. The Committee will have full and final authority in its discretion, at any time and from time to time, subject only to the express terms, conditions and other provisions of the Company's certificate of incorporation, by-laws and this Plan, and the specific limitations on such discretion set forth herein:

i. to select and approve the persons who will be granted Options under this Plan from among the Eligible Participants, and to grant to any person so selected one or more Options to purchase such number of shares of Option Stock as the Committee may determine;

ii. to determine the period or periods of time during which Options may be exercised, the Option Price and the duration of such Options, and other matters to be determined by the Committee in connection with specific Option grants and Option Agreements as specified under this Plan;

iii. to interpret this Plan, to prescribe, amend and rescind rules and regulations relating to this Plan, and to make all other determinations necessary or advisable for the operation and administration of this Plan; and

iv. to delegate all or a portion of its authority under subsections (i) and (ii) of this section 4(b) to one or more directors of the Company who are executive officers of the Company, but only in connection with Options granted to Eligible Participants who are not subject to the reporting and liability provisions of Section 16 of the Securities Exchange Act of 1934, as amended.

c. Limitation on Authority. Notwithstanding the foregoing, or any other provision of this Plan, the Committee will have no authority:

i. to grant Options to any of its members, whether or not approved by the Board; and

ii. to determine any matters, or exercise any discretion, in connection with the Formula Options under section 6(m) hereof, to the extent that the power to make such determinations or to exercise such discretion would cause one or more members of the Committee no longer to be "Disinterested Directors" within the meaning of section 2(i) above.

d. Designation of Option. Except as otherwise provided herein, the Committee will designate any Option granted hereunder either as an ISO or as an NSO.

e. Option Agreements. Options will be deemed granted hereunder only upon the execution and delivery of an Option Agreement by the Optionee and a duly authorized officer of the Company.

5. Shares Reserved for Option.

a. Option Pool. The aggregate number of shares of Option Stock that may be issued pursuant to the exercise of Options granted under this Plan will not exceed one million five hundred thousand (1,500,000) (the "Option Pool").

b. Adjustments Upon Changes in Stock. In the event of any change in the outstanding Stock of the Company as a result of a stock split, reverse stock split, stock dividend, recapitalization, combination or reclassification, appropriate proportionate adjustments will be made.

6. Term of Stock Option Agreements.

Each Option granted pursuant to this Plan will be evidenced by an agreement ("Option Agreement") between the Company and the person to whom such Option is granted, in form and substance satisfactory to the Committee in its sole discretion, consistent with this Plan.

a. Status of Optionee. Nothing contained in this Plan, any Option Agreement or in any other agreement executed in connection with the granting of an Option under this Plan will confer upon any Optionee any right with respect to the continuation of his or her status as an employee of, consultant or independent contractor to, or director of, the Company or its subsidiaries.

b. Vesting Periods. Each Option Agreement may specify the period or periods of time within which each Option or portion thereof will first become exercisable. No Option granted hereunder will be exercisable prior to six months from the date of grant.

c. Exercise of the Option.

i. Mechanics and Notice. An Option may be exercised to the extent exercisable by giving written notice of exercise to the Company, specifying the number of full shares of Option Stock to be purchased and accompanied by full payment of the Option Price thereof and the amount of withholding taxes.

ii. Withholding Taxes. As a condition to the issuance of the shares of Option Stock upon full or partial exercise of an NSO granted under this Plan, the Optionee will pay to the Company in cash, or in such other form as the Committee may determine in its discretion, the amount of the Company's tax withholding liability required in connection with such exercise.

d. Payment of Option Price. Each Option Agreement will specify the Option Price with respect to the exercise of Option Stock thereunder, to be determined by the Committee in its discretion at the time such Option is granted.

e. Termination of the Option. Each Option Agreement will specify the period of time during which the Option granted therein will be exercisable, not to exceed ten years from the date of grant in the case of an ISO.

f. Options Nontransferable. No Option will be transferable by the Optionee otherwise than by will or the laws of descent and distribution, or in the case of an NSO, pursuant to a QDRO.

g. Qualification of Stock. The right to exercise an Option will be subject to the requirement that if the listing, registration or qualification of the shares of Option Stock is necessary or desirable, the Option may not be exercised unless and until such approval is effected or obtained.

h. Additional Restrictions on Transfer. By accepting Options and/or Option Stock under this Plan, the Optionee will be deemed to represent, warrant and agree regarding securities law compliance and investment intent.

i. Compliance with Law. Options may be granted pursuant to this Plan, and Option Stock may be issued pursuant to the exercise thereof only after compliance with applicable federal and state securities laws.

j. Stock Certificate. Certificates representing the Option Stock issued pursuant to the exercise of Options will bear all legends required by law and necessary to effectuate this Plan's provisions.

k. Notices. Any notice to be given to the Company under the terms of an Option Agreement will be addressed to the Company at its principal executive office, Attention: Corporate Secretary.

l. Other Provisions. The Option Agreement may contain such other terms, provisions and conditions as may be determined by the Committee in its sole discretion.

m. Formula Options. On November 1st of each year, following stockholder approval of this Plan, each member of the Board who is not an employee of the Company will be awarded a Formula Option to purchase 10,000 shares of Stock.

7. Proceeds from Sale of Stock.

Cash proceeds from the sale of shares of Option Stock issued from time to time upon the exercise of Options granted pursuant to this Plan will be added to the general funds of the Company and as such will be used from time to time for general corporate purposes.

8. Modification, Extension and Renewal of Options.

Subject to the terms and conditions and within the limitations of this Plan, and except with respect to Formula Options, the Committee may modify, extend or renew outstanding Options granted under this Plan, or accept the surrender of outstanding Options and authorize the granting of new Options in substitution therefor.

9. Amendment and Discontinuance.

The Board may amend, suspend or discontinue this Plan at any time or from time to time; provided that no action of the Board will cause ISOs granted under this Plan not to comply with Section 422 of the Code unless the Board specifically declares such action to be made for that purpose.

10. Plan Compliance with Rule 16b-3.

With respect to persons subject to Section 16 of the Securities Exchange Act of 1934, transactions under this plan are intended to comply with all applicable conditions of Rule 16b-3 or its successors under the 1934 Act.

11. Copies of Plan.

A copy of this Plan will be delivered to each Optionee at or before the time he or she executes an Option Agreement.

Company Name

Date

Authorized Signature

Title

Enter text✕

What the Lynton Group Inc Initial Statement Preliminary Form Is

The Lynton Group Inc Initial Statement Preliminary Form collects basic project, party, and administrative details before a formal agreement or onboarding package is prepared. It standardizes contact information, project identifiers, scope summaries, and required attachments so internal teams and external partners have a consistent record to begin review, approvals, and compliance checks. Using a single preliminary form reduces back-and-forth requests for missing data, creates an audit-ready trail of initial disclosures, and establishes the effective date for later documents and signatures.

Why this preliminary form matters for accuracy and compliance

A clear, standardized initial statement reduces processing delays, lowers rework, and creates a single source of truth for contract intake and compliance review. It supports internal routing, enables consistent eSignature workflows, and helps demonstrate record retention and audit trails for regulatory or tax purposes under ESIGN and UETA frameworks.

Why this preliminary form matters for accuracy and compliance

Who typically completes or reviews the form

Use this form at project intake or when new contractual relationships begin to ensure consistent data capture across teams.

  • Company administrators and contract coordinators who gather initial client and project details for internal tracking and invoicing.
  • Project managers who validate scope, deliverables, and timelines before authorizing formal agreements or work orders.
  • Legal and compliance reviewers who confirm jurisdiction, required disclosures, and whether notarization or witnessing is necessary.

Keep completed forms attached to the project file and route them to legal, finance, and operations as needed for next steps.

Step-by-step: completing the preliminary form

Follow these steps in order to complete, review, and distribute the form so downstream teams can proceed without delays.

  • 01
    Prepare data: Gather IDs, TIN, addresses, and contract summaries before starting.
  • 02
    Complete fields: Enter required information and verify formats against field guidance.
  • 03
    Review internally: Route to legal or finance for compliance and tax checks.
  • 04
    Sign and archive: Obtain signatures, record the audit trail, and attach to project file.

Essential parts of a professional initial statement form

A well-structured preliminary form balances full information capture with clarity so reviewers can quickly validate eligibility, tax, and compliance items before preparing definitive agreements.

Header

Document title, form version, and an effective date field so reviewers can confirm they are using the current intake template.

Parties

Clear party blocks with legal names, DBA names, role (vendor/client), and tax identification to reduce mismatches in subsequent agreements.

Project summary

Concise scope of work, deliverables, location, and estimated timeline to anchor later SOW or contract exhibits.

Compliance fields

Jurisdiction, required disclosures, HIPAA or industry flags, and notarization needs included for routing to legal and records teams.

Attachments

Checklist of supporting documents (W-9, insurance certificate, ID) required before final contract execution or payment setup.

Audit trail

Signature fields, timestamps, and reviewer notes captured to create an auditable record for future review or regulatory inquiry.

Minimum required data elements

Legal name: Exact entity name
Tax ID: EIN or SSN
Contact email: Primary address
Mailing address: Street, city, state, ZIP
Project code: Internal identifier
Signature date: MM/DD/YYYY

Configuring an online workflow for this form

Set up fields, authentication, and storage rules before sending to ensure a compliant, auditable eSubmission.

Field Configuration
Signature Type Electronic signature (click, drawn, or PKI as required)
Authentication Email link, SMS code, or stronger MFA for sensitive submissions
Conditional Fields Show fields only when related checkboxes are selected
Notification Email alerts to reviewer roles on completion

Digital signing, storage, and integration considerations

Choose a platform that supports required authentication, audit trails, and secure storage to meet legal and internal policy needs.

  • Authentication: Email, SMS, or KBA options for signer verification
  • Integrations: Connect to Salesforce, NetSuite, Microsoft 365, Google Workspace
  • File formats: Support for PDF, DOCX, and audit log exports

Where completed forms are sent and how they move through review

A predictable routing model reduces friction across teams; define the recipients and escalation path before sending the form for signature.

  • Intake: Submitted to contract administrator for initial verification
  • Legal review: Forwarded to legal for jurisdiction and disclosure checks
  • Finance: Sent to accounts payable for vendor setup and tax validation
  • Archive: Stored in document repository with audit trail attached

Typical timelines and processing expectations

Establish and communicate standard turnaround times to avoid bottlenecks between intake, review, and signature collection.

Submission timing:

Provide the form at project kickoff or when vendor engagement begins

Internal review:

Allow five business days for legal and finance review

Signature window:

Request signatures be returned within ten business days

Notary scheduling:

Book notarization within 30 days if required

Update requirement:

Amend and refile within ten business days of material changes

eSignature vendor comparison for completing and signing this form

Compare basic pricing and capabilities for common eSignature providers; signNow appears first as the initial column per vendor ordering rules.

signNow DocuSign Adobe Sign PandaDoc HelloSign
Starting Price $8/user/mo $15/user/mo $14/user/mo $19/user/mo $15/user/mo
Free Trial 7-day free trial Varies Varies Varies Varies
Bulk Send Yes Yes Yes Yes No
Audit Trail Yes Yes Yes Yes Yes
HIPAA Compliant Yes Yes Yes No No

Common mistakes to avoid when preparing the preliminary form

  • Entering informal or DBA names instead of the legal entity triggers vendor setup delays and tax mismatches.
  • Omitting the effective date can create ambiguity about when obligations commence and affect enforcement timelines.
  • Failing to attach required supporting documents (W-9, insurance) causes repeated back-and-forth and slows approval.
  • Using inconsistent formats for TINs or dates increases manual correction and risks backup withholding for payments.

Penalties and legal risks from incorrect or incomplete forms

Incorrect TIN: Backup withholding 24%
Late filing: IRS penalties under IRC §6721 may apply
Missing notarization: Document may be unenforceable
Unauthorized signer: Contract vulnerability and repudiation risk
HIPAA breach: Civil penalties and corrective action
I-9 noncompliance: Fines $281–$2,789 per violation

Practical tips for accurate and efficient completion

Use a standardized intake checklist, prefill known fields where possible, and validate key data before routing to reduce rework and processing time.

Use consistent naming conventions
Adopt a corporate standard for legal names and project codes so automated systems and people can match records reliably, reducing vendor setup issues and reconciliation errors.
Validate tax and contact data early
Confirm TINs, addresses, and primary contacts before payment or contract execution to avoid backup withholding, delayed payments, or misdirected notices.
Attach required documents upfront
Bundle W-9, certificates of insurance, signed exhibits, and identification at initial submission to speed approvals and eliminate routine follow-up requests.
Maintain an audit trail
Capture timestamps, signer IPs, and reviewer notes via the eSignature platform to support dispute resolution and compliance audits under ESIGN and UETA.

Real-world examples of the preliminary form in use

These case summaries show how other organizations use a standardized initial statement to speed onboarding and maintain compliance.

Optica Ventures (COO)

Optica standardizes intake to reduce customer confusion and incomplete submissions.

  • They use the preliminary form as a mandatory intake step.
  • The result was fewer follow-ups, faster vendor setup, and improved customer experience across deal pipelines.

Fertility Centers of Illinois (Founder)

The clinic digitized intake to enforce consistent consent and data capture.

  • Prelim forms include HIPAA flags and required attachments.
  • This produced audit-ready patient onboarding records, simplified compliance reviews, and reduced document handling time.

Frequently asked questions about the preliminary form and eSubmission

Answers to common questions about signature validity, notarization, corrections after signing, and data retention to help teams avoid routine compliance pitfalls.


Need help? Contact support

be ready to get more
Join over 28 million airSlate SignNow users